Continuing Education Activity

Vohwinkel syndrome, also known as keratoderma hereditarian mutilans, is a rare and complex genetic disorder. This condition primarily affects the skin, resulting in palmoplantar keratoderma, characterized by thickened skin on the palms and soles. The keratoderma often forms a star-like pattern on the knuckles. Individuals with Vohwinkel Syndrome may experience pseudoainhum, a constriction of the fingers or toes, which can ultimately lead to autoamputation of the affected digits. Hearing impairment is another significant aspect of the syndrome, with cochlear involvement often requiring audiological assessment and possible cochlear implantation for management. This activity reviews the genetic basis, clinical manifestations, and treatment of Vohwinkel syndrome patients and highlights the role of the interprofessional team in improving care for affected patients. 

Objectives:

• Identify the pathophysiology of Vohwinkel syndrome.
• Differentiate Vohwinkel syndrome from other dermatological conditions with similar features based on clinical assessment and genetic testing.
• Apply evidence-based treatment options to manage patients with Vohwinkel syndrome.
• Collaborate with an interprofessional team to ensure comprehensive care and management of patients affected by Vohwinkel syndrome, fostering a multidisciplinary approach to treatment.

Introduction

Vohwinkel syndrome, also known as keratoderma hereditarian mutilans, is classified as a type of hereditary palmoplantar keratoderma (PPK).[1] PPKs exist on a spectrum from inherited to acquired and can range in their presentation. A PPK may be an isolated finding or part of a syndrome with extracutaneous involvement. Rarely a PPK can be drug-induced or part of a paraneoplastic process.[2]

The classic Vohwinkel syndrome is a hereditary PPK associated with "starfish" keratoses on the knuckles, a PPK in a "honeycomb" pattern, hearing impairment, and mutilating digital constriction bands (pseudoainhum) that often lead to autoamputation of the affected digit(s).[3][4]

A variant of Vohwinkel syndrome, loricrin keratoderma, presents as a honeycomb PPK with pseudoainhum with the addition of ichthyosis; deafness is not a feature of this ichthyosiform variant.[5]

Etiology

Classic Vohwinkel syndrome is inherited in an autosomal dominant (AD) fashion. It is caused by a mutation in the gap junction beta 2 (GJB2) gene located on chromosome 13q11-12, which encodes the protein connexin 26.[6]

Loricrin keratoderma, the ichthyosiform variant of Vohwinkel syndrome, is caused by LOR mutations; this is the gene on the epidermal differentiation complex (EDC) on chromosome 1q21 that encodes loricrin.[7][8] Loricrin is a protein component of the cornified envelope, and therefore, mutations in loricrin lead to the ichthyosis that differentiates this variant from classic Vohwinkel syndrome. Because there is no gap junction protein mutation, deafness is not a feature of this variant.

Epidemiology

Vohwinkel syndrome is extremely rare, with <50 reported cases in the literature. Males and females are equally affected between infancy and early childhood.

Pathophysiology

Two mutations of the EDC have been identified in Vohwinkel syndrome. One is a missense mutation of the GJB2 gene coding connexin-26, a gap junction protein. This mutation on chromosome 13 is associated with the classic (hearing loss–associated) Vohwinkel syndrome. The pathophysiology of classic Vohwinkel syndrome is, in part, explained by the role of connexin proteins in forming the building blocks for gap junctions. The connexin proteins that compose gap junctions are integral for transporting nutrients, ions, and neurotransmitters from cell to cell. Connexin proteins are ubiquitous throughout the human body, including the cochlea of the inner ear, and are responsible for forming gap junctions or transport channels for signaling molecules between cells. Specifically, connexin 26 is found in the epidermis of palmoplantar skin, sweat glands, and cochlea.[9] The channels formed by connexin 26 are responsible for transporting potassium ions that convert sound waves into electoral nerve impulses and, therefore, normal hearing.[10] There are several human connexin disorders caused by mutations in gap junction proteins that result in deafness. Mutations in connexin 26 are linked to Vohwinkel syndrome, keratitis-ichthyosis deafness and hystrix-like ichthyosis deafness syndromes, palmoplantar keratoderma with deafness, deafness with Clouston-like phenotype, and Bart-Pumphrey syndrome.[1]

Another mutation is an insertional mutation of the loricrin gene on the EDC on chromosome 1q21. The pathophysiology of loricrin keratoderma, a Vohwinkel variant, can be appreciated by recognizing the role that the loricrin protein plays in the cornified envelope and the importance of the cornified envelope in maintaining the integrity of the stratum corneum. The stratum corneum is the outermost layer of the epidermis that serves as a barrier to transepidermal water loss.[11] The stratum corneum is made up of corneocytes, and each corneocyte is surrounded by a cornified envelope “shell.” Loricrin is an integral protein of the cornified envelope.[12] When the LOR gene is mutated, the structure of the loricrin protein is distorted and cannot make its way into the cornified envelope. This leads to transepidermal water loss and resultant ichthyosis.

Histopathology

There are no specific histologic findings in Vohwinkel disease. Nonspecific findings include prominent orthohyperkeratosis (pertaining to the PPK), as well as papillomatosis.[13] The constricting bands consist of fibrous connective tissue resembling scars.

History and Physical

Vohwinkel syndrome is characterized by a PPK, digital constriction bands (pseudoainhum), and hearing impairment/deafness. The PPK begins within the first few years of life and appears as a callus-like thickening on the palms and soles and is often referred to as having a “honeycomb” pattern.[14] Patients also present with starfish-shaped “knuckle pads,” or thick skin plaques on the dorsal surfaces of their fingers, toes, and/or knees. They may also have linear keratoses on their elbows and knees. A characteristic (albeit not pathognomonic) feature of Vohwinkel is the development of fibrous constriction bands encasing the fingers and toes, often referred to as pseudoainhum. This pseudoainhum presents in late childhood or adulthood. Pseudoainhum is associated with the autoamputation of digits.[15][16][4] A high-frequency, nonprogressive hearing loss is also present. This hearing loss is often not appreciated until after infancy. Another less characteristic but a potential finding is scarring alopecia.

The loricrin variant presents as mild, generalized ichthyosis with accentuation of the ichthyosis in flexural surfaces.[8]

Evaluation

The diagnosis of Vohwinkel syndrome is mainly made clinically. Audiometry is indicated to evaluate the nature and extent of hearing loss and for eventual follow-up. Radiographs of the hands and feet are used to detect any abnormalities of the underlying bones. Craniofacial studies can be performed if clinical findings justify them. Histologic findings are non-specific. Genetic testing is available to identify the genetic mutation.[6]

Treatment / Management

The hyperkeratotic callus-like lesions (PPK) are often improved with oral retinoids such as isotretinoin.[17] Debridement with a blade followed by applying a keratolytic agent (urea, lactic acid, and salicylic acid-containing creams and lotions) under occlusion is often helpful.

Another major aspect of treatment is aimed at releasing the digital constriction bands found in pseudoainhum. Historically, surgery to release these digital constriction bands (Z-plasty, other methods for relaxing scars) was commonplace; however, there is increasing evidence to support the use of low-dose oral retinoids to prevent and/or treat the pseudoainhum to avoid autoamputation or surgery.[18] Low-dose isotretinoin was reported to prevent digital amputation.[16] Systemic retinoids can reverse both the keratoderma and pseudoainhum; however, relapse is the rule upon discontinuation of treatment.

Hearing testing is indicated in any patient with Vohwinkel syndrome features, and cochlear implants are often performed.

A recent study suggested that low doses of transforming growth factor β1 (TGF-β1) can improve the proliferation of Vohwinkel syndrome, providing new insights into its treatment.[19]

Differential Diagnosis

The differential diagnosis for classic Vohwinkel syndrome includes other PPKs with hearing impairment. These include Bart-Pumphrey syndrome, which presents as a non-mutilating PPK with deafness, knuckle pads, and leukonychia. Bart-Pumphrey syndrome lacks the starfish-shaped keratoses and the honeycomb pattern of the PPK.[14][20]

The differential diagnosis for mutilating PPKs (PPKs with digital constriction bands) includes Olmsted syndrome, Papillon-Lefevre syndrome, Loricrin keratoderma, and Mal de Meleda.[21][22][23][24]

The differential diagnosis for pseudoainhum includes vascular abnormalities (Raynaud disease, scleroderma, diabetes mellitus), infections (leprosy, tertiary syphilis, yaws), and scar formation following ergot poisoning. 

Prognosis

The prognosis of Vohwinkel syndrome is overall good but can have profound implications for those diagnosed with it. The prognosis of affected patients can vary widely depending on several factors, including the severity of their condition, the timing of diagnosis, and the effectiveness of the management strategies employed. While Vohwinkel Syndrome is a chronic and progressive disorder, early diagnosis and comprehensive care can significantly improve the long-term prognosis. The condition is associated with an average lifespan.[25]

The dermatological manifestations, such as palmoplantar keratoderma and pseudoainhum, can be managed with regular dermatological assessments, wound care, and topical treatments, potentially preserving hand and foot function.

Hearing impairment is a common and challenging aspect of the syndrome, often necessitating cochlear implants for effective intervention. 

Complications

Complications of Vohwinkel syndrome include the following:

• Autoamputation of digits with functional impairment of the limbs                                                             
• Persistent keratoderma[3]
• Secondary skin infections
• Hearing loss in the classic variant
• Squamous cell carcinoma has been documented in 2 cases
• Social isolation
• Psychological distress

Consultations

Dermatology, hand surgery, otolaryngology (ENT), audiology, and genetic counselors should be involved in caring for patients with Vohwinkel syndrome. A multidisciplinary approach is essential for achieving better outcomes and patient-centered care.

Deterrence and Patient Education

Deterrence and patient education are crucial in managing Vohwinkel Syndrome. Deterrence primarily involves preventing complications and worsening of symptoms through proactive measures. Patients should be educated about the importance of regular dermatological care to manage skin thickening, as well as strategies to maintain proper skin hydration and prevent fissures, which can lead to infections. Promoting vigilant audiological monitoring can deter the progression of hearing impairment associated with the syndrome.

Patient education serves as a cornerstone of managing Vohwinkel Syndrome, empowering individuals and their caregivers with the knowledge and tools to effectively mitigate the impact of this condition on their quality of life. It is also essential in dispelling misconceptions and fostering early diagnosis, which can lead to better outcomes and potentially innovative therapies in the future.

Given the condition is inherited in an autosomal dominant pattern, patients should consider genetic counseling.

Enhancing Healthcare Team Outcomes

Managing Vohwinkel syndrome necessitates a spectrum of skills among healthcare professionals. Interprofessional collaboration is an essential component of care for any syndromic disease that presents with a constellation of findings. A primary care doctor, dermatologist, surgeon, and ENT often work together to provide Vohwinkel patients with the best possible outcome and enhance treatment outcomes. Physicians and advanced care practitioners should have the expertise to diagnose and monitor the dermatological features identifying complications like infections. Nurses require proficiency in wound care and dermatological assessments. Audiologists must possess specialized knowledge in hearing assessment, while pharmacists should understand medications relevant to the condition. Genetic counselors can help patients and families understand the hereditary implications. Effective communication among the interprofessional healthcare team is vital. Regular meetings and discussions allow for the exchange of information. 

It may be prudent for the patient to establish care at a multi-specialty care clinic to ease coordination of care, access to laboratory data and encounter notes between healthcare professionals, and convenience for the patient, leading to a better quality of life. Multi-specialty “hubs” have been linked to lower hospital admission rates, higher patient satisfaction, and improved quality of care overall. A holistic approach to care improves patient safety and ensures that all aspects of Vohwinkel syndrome management are coordinated seamlessly.

Review Questions

• Access free multiple choice questions on this topic.
• Click here for a simplified version.
• Comment on this article.

References

1.

Avshalumova L, Fabrikant J, Koriakos A. Overview of skin diseases linked to connexin gene mutations. Int J Dermatol. 2014 Feb;53(2):192-205. [PubMed: 23675785]

2.

Kallini JR, Sadeghani K, Khachemoune A. Paraneoplastic palmoplantar keratoderma secondary to metastatic uterine adenocarcinoma. Cutis. 2017 Mar;99(3):E32-E35. [PubMed: 28398428]

3.

Zhang M, Song K, Ding N, Shu C, Wang Y. Using a Distant Abdominal Skin Flap to Treat Digital Constriction Bands: A Case Report for Vohwinkel Syndrome. Medicine (Baltimore). 2016 Feb;95(6):e2762. [PMC free article: PMC4753922] [PubMed: 26871826]

4.

Prabhu R, Kannan NS, Vinoth S, Praveen CB. Ainhum - A Rare Case Report. J Clin Diagn Res. 2016 Apr;10(4):PD17-8. [PMC free article: PMC4866186] [PubMed: 27190888]

5.

Reinehr CPH, Peruzzo J, Cestari T. Vohwinkel syndrome: ichthyosiform variant in a family. An Bras Dermatol. 2018 Sep-Oct;93(5):723-725. [PMC free article: PMC6106675] [PubMed: 30156625]

6.

Ozturk S, Can I, Eser B, Yazici H. A Deletion Mutation of the Connexin 26 (Gjb2) Gene in a Turkish Patient with Vohwinkel Syndrome . Genet Couns. 2016;27(2):187-91. [PubMed: 29485809]

7.

Khalil S, Daou L, Hayashi R, Abbas O, Nemer G, Saadeh D, Shimomura Y, Kurban M. Identification of a novel mutation in the LOR gene in an Iraqi patient with loricrin keratoderma resembling epidermolytic hyperkeratosis. J Eur Acad Dermatol Venereol. 2017 Mar;31(3):e142-e144. [PubMed: 27520397]

8.

Stypczyńska E, Placek W, Zegarska B, Czajkowski R. Keratinization Disorders and Genetic Aspects in Palmar and Plantar Keratodermas. Acta Dermatovenerol Croat. 2016 Jun;24(2):116-23. [PubMed: 27477171]

9.

Moscato S, Cabiati M, Bianchi F, Vaglini F, Morales MA, Burchielli S, Botta L, Sabbatini ARM, Falleni A, Del Ry S, Mattii L. Connexin 26 Expression in Mammalian Cardiomyocytes. Sci Rep. 2018 Sep 18;8(1):13975. [PMC free article: PMC6143590] [PubMed: 30228305]

10.

Mammano F. Inner Ear Connexin Channels: Roles in Development and Maintenance of Cochlear Function. Cold Spring Harb Perspect Med. 2019 Jul 01;9(7) [PMC free article: PMC6601451] [PubMed: 30181354]

11.

Wertz PW. Lipids and the Permeability and Antimicrobial Barriers of the Skin. J Lipids. 2018;2018:5954034. [PMC free article: PMC6139190] [PubMed: 30245886]

12.

Murphrey MB, Miao JH, Zito PM. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Nov 14, 2022. Histology, Stratum Corneum. [PubMed: 30020671]

13.

Sinha M, Watson SB. Keratoderma hereditarium mutilans (Vohwinkel syndrome). J Hand Surg Eur Vol. 2009 Apr;34(2):235-7. [PubMed: 19282408]

14.

Dippold S, Butsch F, Schopf R, Keilmann A. [Vohwinkel syndrome. Hearing loss and keratoderma on the hands and feet]. HNO. 2013 Jul;61(7):617-9. [PubMed: 23247752]

15.

Camisa C, Rossana C. Variant of keratoderma hereditaria mutilans (Vohwinkel's syndrome). Treatment with orally administered isotretinoin. Arch Dermatol. 1984 Oct;120(10):1323-8. [PubMed: 6237617]

16.

Nico MMS, Fernandes JD. Low-dose isotretinoin prevents digital amputation in loricrin keratoderma (Vohwinkel syndrome with ichthyosis). J Dtsch Dermatol Ges. 2017 Jun;15(6):665-667. [PubMed: 28591443]

17.

Wang B, Zhang Z, Huang X, Lin X, Qu W, Zhou Y. Successful treatment of mutilating palmoplantar keratoderma with acitretin capsule and adapalene gel: a case report with review of the literature. J Eur Acad Dermatol Venereol. 2016 Jan;30(1):169-72. [PubMed: 25200571]

18.

Behera B, Chandrashekar L, Singh N, Thappa DM, Gochhait D. Lamellar ichthyosis associated bilateral pseudoainhum of fingers and toes successfully treated with tazarotene. Dermatol Ther. 2017 Sep;30(5) [PubMed: 28730635]

19.

Ling X, Dong S, Zhang L. Low dose TGF-β1 can improve vohwinkel syndrome by promoting the proliferation of keratinocytes. Acta Histochem. 2023 Feb;125(2):152010. [PubMed: 36738515]

20.

Hyman CH, Cohen PR. Report of a family with idiopathic knuckle pads and review of idiopathic and disease-associated knuckle pads. Dermatol Online J. 2013 May 15;19(5):18177. [PubMed: 24011277]

21.

Choi JY, Kim SE, Lee SE, Kim SC. Olmsted Syndrome Caused by a Heterozygous p.Gly568Val Missense Mutation in TRPV3 Gene. Yonsei Med J. 2018 Mar;59(2):341-344. [PMC free article: PMC5823840] [PubMed: 29436206]

22.

Mohanty P, Dash G, Mohapatra L, Puhan MR. Olmsted syndrome in three sisters in a family. Indian J Dermatol Venereol Leprol. 2018 Jul-Aug;84(4):522. [PubMed: 28799532]

23.

Bukharia A, Komal S, Sudhanan VM, Chaudhary SS. Olmsted Syndrome: Rare Occurrence in Four Siblings. Indian J Dermatol. 2016 May-Jun;61(3):347. [PMC free article: PMC4885203] [PubMed: 27293270]

24.

Xie W, Wang Q, Zhou F, Zhao X, Zhu C. [Diffuse palmoplanta keratoderma: a pedigree with 23 cases]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018 Apr 10;35(2):307-308. [PubMed: 29653014]

25.

Pisoh T, Bhatia A, Oberlin C. Surgical correction of pseudo-ainhum in Vohwinkel syndrome. J Hand Surg Br. 1995 Jun;20(3):338-41. [PubMed: 7561409]

Disclosure: Dahlia Saleh declares no relevant financial relationships with ineligible companies.

Disclosure: Haitham Saleh declares no relevant financial relationships with ineligible companies.

Disclosure: Laura Tanner declares no relevant financial relationships with ineligible companies.